Comparison of the efficacy and safety of 1.5 compared with 3.0 g oral slow-release mesalazine (Pentasa) in the maintenance treatment of ulcerative colitis. Dutch Pentasa Study Group. - Fockens,P.; Mulder,C.J.; Tytgat,G.N. (Eur J Gastroenterol Hepatol, 1995)